The activity of atovaquone in patients with oligosymptomatic Plasmodium falciparum malaria was assessed in an open, non-comparative clinical study. The patients showed a good clinical response, but there was a high rate of recrudescence. The activity of atovaquone in combination with another antimalarial agent should be investigated.
No takes yet. Share an insight, caveat, or question.
Chiodini et al. (1995) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: